IMMUNOVANT, INC. Capital Expenditures
IMMUNOVANT, INC. (IMVT) reported Capital Expenditures of $8.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-20.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-05-20
- IMMUNOVANT, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $8.00K, a 96.02% decline year-over-year.
- IMMUNOVANT, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- IMMUNOVANT, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- IMMUNOVANT, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- IMMUNOVANT, INC. payments to acquire property, plant, and equipment for fiscal 2026 was $8.00K, a 98.95% decline from fiscal 2025.
- IMMUNOVANT, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $759.00K, a 110.83% increase from fiscal 2024.
- IMMUNOVANT, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $360.00K, a 82.74% increase from fiscal 2023.
- IMMUNOVANT, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $197.00K, a 22.44% decline from fiscal 2022.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-03-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $8.00K derived: sum of 2 quarters · filed 2026-05-20 | $8.00K derived: sum of 3 quarters · filed 2026-05-20 | $8.00K 10-K · filed 2026-05-20 |
| 2025-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $0.00 derived: sum of 2 quarters · filed 2026-02-06 | $0.00 10-Q · filed 2026-02-06 | $201.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $201.00K derived: sum of 3 quarters · filed 2026-05-20 | $381.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 | $201.00K derived: sum of 2 quarters · filed 2026-05-20 | $381.00K derived: sum of 3 quarters · filed 2026-05-20 | $577.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-03-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $381.00K derived: sum of 2 quarters · filed 2026-05-20 | $577.00K derived: sum of 3 quarters · filed 2026-05-20 | $759.00K 10-K · filed 2026-05-20 |
| 2024-12-31 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $376.00K derived: sum of 2 quarters · filed 2026-02-06 | $558.00K 10-Q · filed 2026-02-06 | $708.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-09-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | $378.00K 10-Q · filed 2025-11-10 | $528.00K derived: sum of 3 quarters · filed 2026-05-20 | $659.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-06-30 | $182.00K 10-Q · filed 2025-08-11 | $332.00K derived: sum of 2 quarters · filed 2026-05-20 | $463.00K derived: sum of 3 quarters · filed 2026-05-20 | $497.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-03-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $281.00K derived: sum of 2 quarters · filed 2026-05-20 | $315.00K derived: sum of 3 quarters · filed 2026-05-20 | $360.00K 10-K · filed 2026-05-20 |
| 2023-12-31 | $131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | $165.00K derived: sum of 2 quarters · filed 2025-02-06 | $210.00K 10-Q · filed 2025-02-06 | $236.00K derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-09-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $79.00K 10-Q · filed 2024-11-07 | $105.00K derived: sum of 3 quarters · filed 2025-05-29 | $203.00K derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-06-30 | $45.00K 10-Q · filed 2024-08-06 | $71.00K derived: sum of 2 quarters · filed 2025-05-29 | $169.00K derived: sum of 3 quarters · filed 2025-05-29 | $200.00K derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-03-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $124.00K derived: sum of 2 quarters · filed 2025-05-29 | $155.00K derived: sum of 3 quarters · filed 2025-05-29 | $197.00K 10-K · filed 2025-05-29 |
| 2022-12-31 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | $129.00K derived: sum of 2 quarters · filed 2024-02-12 | $171.00K 10-Q · filed 2024-02-12 | $289.00K derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-09-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | $73.00K 10-Q · filed 2023-11-09 | $191.00K derived: sum of 3 quarters · filed 2023-11-09 | $265.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $42.00K 10-Q · filed 2023-08-10 | $160.00K derived: sum of 2 quarters · filed 2023-08-10 | $234.00K derived: sum of 3 quarters · filed 2023-08-10 | $278.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-22 | $192.00K derived: sum of 2 quarters · filed 2023-05-22 | $236.00K derived: sum of 3 quarters · filed 2023-05-22 | $254.00K 10-K · filed 2023-05-22 |
| 2021-12-31 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-03 | $118.00K derived: sum of 2 quarters · filed 2023-02-03 | $136.00K 10-Q · filed 2023-02-03 | $231.00K derived: sum of 4 quarters · filed 2023-02-03 |
| 2021-09-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-04 | $62.00K 10-Q · filed 2022-11-04 | $157.00K derived: sum of 3 quarters · filed 2022-11-04 | $186.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $18.00K 10-Q · filed 2022-08-05 | $113.00K derived: sum of 2 quarters · filed 2022-08-05 | $142.00K derived: sum of 3 quarters · filed 2022-08-05 | $181.00K derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-08 | $124.00K derived: sum of 2 quarters · filed 2022-06-08 | $163.00K derived: sum of 3 quarters · filed 2022-06-08 | $210.00K 10-K · filed 2022-06-08 |
| 2020-12-31 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-04 | $68.00K derived: sum of 2 quarters · filed 2022-02-04 | $115.00K 10-Q · filed 2022-02-04 | $125.00K derived: sum of 4 quarters · filed 2022-02-04 |
| 2020-09-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-05 | $86.00K 10-Q · filed 2021-11-05 | $96.00K derived: sum of 3 quarters · filed 2021-11-05 | $109.00K derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $47.00K 10-Q · filed 2021-08-09 | $57.00K derived: sum of 2 quarters · filed 2021-08-09 | $70.00K derived: sum of 3 quarters · filed 2021-08-09 | $78.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-01 | $23.00K derived: sum of 2 quarters · filed 2021-06-01 | $31.00K derived: sum of 3 quarters · filed 2021-06-01 | $31.00K 10-K · filed 2021-06-01 |
| 2019-12-31 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $21.00K derived: sum of 2 quarters · filed 2021-02-16 | $21.00K 10-Q · filed 2021-02-16 | $21.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | $8.00K 10-Q · filed 2020-11-12 | $8.00K derived: sum of 3 quarters · filed 2020-11-12 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-12 | $0.00 derived: sum of 2 quarters · filed 2020-08-12 | ||
| 2019-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | $52.00K 10-K · filed 2020-06-29 | ||
| 2018-12-31 | $52.00K 10-Q · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |